Literature DB >> 2170241

Quenching of tyrosine radicals of M2 subunit from ribonucleotide reductase in tumor cells by different antitumor agents: an EPR study.

B Liermann1, G Lassmann, P Langen.   

Abstract

The inhibition of ribonucleotide reductase (RR) of intact Ehrlich ascites tumor cells by different antitumor agents was compared using EPR spectroscopy. The inactivation of M2 subunit was measured via quenching of the functionally essential tyrosine radical. Inhibitors of different classes, for example, hydroxyurea, pyrogallol, and thiosemicarbazones, differ in their efficiency by three orders of magnitude. Most effective inhibition was found for isoquinoline-1-aldehyde-thiosemicarbazone (IQ-1) with an IC50 value of 0.18 microM. Inhibition of RR inside tumor cells is comparable with that reported for isolated enzymes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170241     DOI: 10.1016/0891-5849(90)90042-h

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  3 in total

1.  Ribonucleotide reductase in melanoma tissue. EPR detection in human amelanotic melanoma and quenching of the tyrosine radical by 4-hydroxyanisole.

Authors:  G Lassmanm; B Liermann; W Arnold; K Schwabe
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Effect of hydroxyurea on procyclic Trypanosoma brucei: an unconventional mechanism for achieving synchronous growth.

Authors:  Arnab Roy Chowdhury; Zhixing Zhao; Paul T Englund
Journal:  Eukaryot Cell       Date:  2007-12-14

3.  Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition.

Authors:  Iuliana Besleaga; Iryna Stepanenko; Tatsiana V Petrasheuskaya; Denisa Darvasiova; Martin Breza; Marta Hammerstad; Małgorzata A Marć; Alexander Prado-Roller; Gabriella Spengler; Ana Popović-Bijelić; Eva A Enyedy; Peter Rapta; Anatoly D Shutalev; Vladimir B Arion
Journal:  Inorg Chem       Date:  2021-07-19       Impact factor: 5.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.